UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Qurient unveils P2a trial results for atopic dermatitis treatment in US
Qurient said Monday that it has presented the phase 2a clinical trial resul...
by Lee Han-soo
|
2019-03-04 14:16
라인
US trade agency begins probe into Medytox’s complaint about Daewoong
Medytox said Monday that the U.S. International Trade Commission has starte...
by Lee Han-soo
|
2019-03-04 11:16
라인
Bridge Biotherapeutics to accelerate global presence
Lee Jung-kue, CEO of Bridge Biotherapeutics, is making noticeable strides i...
by Lee Han-soo
|
2019-03-04 10:50
라인
Doctors, medical students struggled for Korea’s independence from Japanese colonialists
This year marks the 100th anniversary of the March 1 Independence Movement,...
by Lee Han-soo
|
2019-03-01 07:36
라인
BioGenetics inks deal to supply biliary tract cancer drug in Korea
BioGenetics said it has signed a deal with Singapore-based drugmaker Aslan ...
by Lee Hye-seon
|
2019-02-28 16:49
라인
Hospitals still force new residents to pay ‘entry fee’
Hospitals are still forcing trainee physicians to pay a large amount of cas...
by Song Soo-youn
|
2019-02-28 16:47
라인
GC starts P1 trials of hemophilia treatment
GC said Thursday that it has administered the first dose of MG1113, a hemop...
by Lee Han-soo
|
2019-02-28 16:45
라인
Bukwang to sell Novartis’ chronic hepatitis B treatment
Bukwang Pharmaceutical said Thursday that it has just begun domestic market...
by Lee Han-soo
|
2019-02-28 14:59
라인
‘Nurses were independence fighters during March 1 Movement’
On Friday this week, the nation marks the 100th anniversary of the March 1 ...
by Lee Min-ju
|
2019-02-28 14:58
라인
Chong Kun Dang topped clinical trials in 2018
Local drugmaker Chong Kun Dang won approval for clinical trials the most am...
by Lee Hye-seon
|
2019-02-28 10:50
라인
Korea, China to cooperate for regulations on drugs, medical devices, cosmetics
Korea and China agreed to strengthen cooperation for regulations on pharmac...
by Lee Hye-seon
|
2019-02-27 22:41
라인
Korea’s 30th novel drug K-Cab to get insurance benefit from March
Korea’s 30th novel medicine K-Cab Tab. (ingredient: tegoprazan) will receiv...
by Lee Hye-seon
|
2019-02-27 16:47
라인
Korea to host annual Congress of Asian Society of Head and Neck Oncology
The sixth Congress of Asian Society of Head and Neck Oncology (ASHNO) will ...
by Lee Han-soo
|
2019-02-27 14:09
라인
Korea’s drug exports hit record high in 2018, industry group says
Won Hee-mok, president of the Korea Pharmaceutical and Bio-Pharma Manufactu...
by Kim Yun-mi
|
2019-02-27 13:08
라인
Korea to phase out consigned bioequivalence tests
The government said it would gradually scrap the “consigned bioequivalence ...
by Lee Hye-seon
|
2019-02-27 12:16
라인
National Cancer Center finds mechanism of cancer progression in osteosarcoma
Researchers at the National Cancer Center have revealed the mechanism of ca...
by Lee Han-soo
|
2019-02-27 11:09
라인
Roche Diagnostics gets reimbursement for ALK diagnostic method
Roche Diagnostics Korea said Wednesday that Ventana anti-ALK CDx Assay, a c...
by Lee Han-soo
|
2019-02-27 11:09
라인
‘Multi-department treatment increases survival rate of liver cancer’
Researchers at Samsung Medical Center have found that a multi-department tr...
by Lee Han-soo
|
2019-02-26 17:01
라인
GC unveils P1 results for hepatitis B treatment
GC said Monday that it has presented the phase 1 clinical trial results for...
by Lee Han-soo
|
2019-02-26 16:07
라인
‘Heat-not-burn cigarettes as risky as traditional ones’
An expert pointed out how harmful so-called “heat-not-burn” cigarettes coul...
by Kim Yun-mi
|
2019-02-26 15:45
-
이전
141
142
143
144
145
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top